ZA886716B - Combination of phosphodiesterase inhibitor and thromboxane a2 antagonist - Google Patents
Combination of phosphodiesterase inhibitor and thromboxane a2 antagonistInfo
- Publication number
- ZA886716B ZA886716B ZA886716A ZA886716A ZA886716B ZA 886716 B ZA886716 B ZA 886716B ZA 886716 A ZA886716 A ZA 886716A ZA 886716 A ZA886716 A ZA 886716A ZA 886716 B ZA886716 B ZA 886716B
- Authority
- ZA
- South Africa
- Prior art keywords
- thromboxane
- antagonist
- combination
- phosphodiesterase inhibitor
- phosphodiesterase
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9610787A | 1987-09-11 | 1987-09-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA886716B true ZA886716B (en) | 1990-05-30 |
Family
ID=22255374
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA886716A ZA886716B (en) | 1987-09-11 | 1988-09-09 | Combination of phosphodiesterase inhibitor and thromboxane a2 antagonist |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0306846A3 (en) |
| JP (1) | JPH01100118A (en) |
| KR (1) | KR890004700A (en) |
| AU (2) | AU2201888A (en) |
| DK (1) | DK500388A (en) |
| IL (1) | IL87721A0 (en) |
| ZA (1) | ZA886716B (en) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0784381B2 (en) * | 1989-05-11 | 1995-09-13 | 田辺製薬株式会社 | Thromboxane A ▲ 2 ▼ Antagonist |
| JPH0372419A (en) * | 1989-05-16 | 1991-03-27 | Tanabe Seiyaku Co Ltd | Reversal agent against thromboxane a2 |
| DE4001622A1 (en) * | 1990-01-20 | 1991-07-25 | Thomae Gmbh Dr K | ORAL DRUGS OF PIMOBENDAN |
| AU5772396A (en) * | 1995-05-19 | 1996-11-29 | Chiroscience Limited | 3,4-disubstituted-phenylsulphonamides and their therapeutic use |
| DE102004011512B4 (en) | 2004-03-08 | 2022-01-13 | Boehringer Ingelheim Vetmedica Gmbh | Pharmaceutical preparation containing pimobendan |
| EP1579862A1 (en) | 2004-03-25 | 2005-09-28 | Boehringer Ingelheim Vetmedica Gmbh | Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure |
| US8980894B2 (en) | 2004-03-25 | 2015-03-17 | Boehringer Ingelheim Vetmedica Gmbh | Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure |
| EP1920785A1 (en) | 2006-11-07 | 2008-05-14 | Boehringer Ingelheim Vetmedica Gmbh | Liquid preparation comprising a complex of pimobendan and cyclodextrin |
| ES2436716T3 (en) | 2008-11-25 | 2014-01-03 | Boehringer Ingelheim Vetmedica Gmbh | Pimobendan for use in the treatment of hypertrophic cardiomyopathy in cats |
| ES2924478T3 (en) | 2012-03-15 | 2022-10-07 | Boehringer Ingelheim Vetmedica Gmbh | Formulation of pharmaceutical tablets for the veterinary medical sector, method of production and use thereof |
| CN105377235A (en) | 2013-07-19 | 2016-03-02 | 勃林格殷格翰动物保健有限公司 | Preserved etherified cyclodextrin derivatives containing liquid aqueous pharmaceutical composition |
| BR112016011111B1 (en) | 2013-12-04 | 2022-11-16 | Boehringer Ingelheim Vetmedica Gmbh | IMPROVED PHARMACEUTICAL COMPOSITIONS OF PIMOBENDAN |
| US10537570B2 (en) | 2016-04-06 | 2020-01-21 | Boehringer Ingelheim Vetmedica Gmbh | Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease |
| KR102199332B1 (en) * | 2019-01-30 | 2021-01-06 | 한국생산기술연구원 | Smart mixing device for confectionery and bakery using multiple mixing bowls with different colors |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4568676A (en) * | 1983-11-25 | 1986-02-04 | Thomas Jefferson University | Method of inhibiting aggregation using thromboxane synthetase inhibitor in combination with a cyclic AMP phosphodiesterase inhibitor |
| FR2596395B1 (en) * | 1986-03-26 | 1989-05-26 | Roussel Uclaf | NOVEL STEROIDS COMPRISING A SPIRANIC CYCLE IN POSITION 17, THEIR PREPARATION METHOD, THEIR APPLICATION AS MEDICAMENTS AND THE COMPOSITIONS CONTAINING THEM |
| DE3631294A1 (en) * | 1986-09-13 | 1988-03-24 | Thomae Gmbh Dr K | NEW SYNERGISTIC COMBINATION CONSISTING OF A PHOSPHODIESTERASE INHIBITOR AND A THROMBOXAN-A (ARROW DOWN) 2 (ARROW DOWN) ANTAGONISTS AND THEIR USE OR THEIR USE. MANUFACTURING |
-
1988
- 1988-09-02 EP EP88114315A patent/EP0306846A3/en not_active Withdrawn
- 1988-09-09 JP JP63226292A patent/JPH01100118A/en active Pending
- 1988-09-09 IL IL87721A patent/IL87721A0/en unknown
- 1988-09-09 KR KR1019880011632A patent/KR890004700A/en not_active Application Discontinuation
- 1988-09-09 ZA ZA886716A patent/ZA886716B/en unknown
- 1988-09-09 AU AU22018/88A patent/AU2201888A/en not_active Abandoned
- 1988-09-09 DK DK500388A patent/DK500388A/en not_active Application Discontinuation
- 1988-09-16 AU AU22246/88A patent/AU620341B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| AU2224688A (en) | 1989-03-16 |
| DK500388A (en) | 1989-03-12 |
| EP0306846A3 (en) | 1990-05-02 |
| KR890004700A (en) | 1989-05-09 |
| EP0306846A2 (en) | 1989-03-15 |
| AU620341B2 (en) | 1992-02-20 |
| AU2201888A (en) | 1989-04-27 |
| IL87721A0 (en) | 1989-02-28 |
| JPH01100118A (en) | 1989-04-18 |
| DK500388D0 (en) | 1988-09-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL88273A0 (en) | Renin inhibitors | |
| ZA886716B (en) | Combination of phosphodiesterase inhibitor and thromboxane a2 antagonist | |
| HU893412D0 (en) | Inhibitors of interleucin-1 | |
| ZA882603B (en) | Inhibitors of angiogenin | |
| GB2207866B (en) | Use of metal chelates as mulluscicides | |
| GB8621381D0 (en) | Protection of metal surfaces | |
| GB8808928D0 (en) | Combination of measuring tool & sharp-edged tool | |
| GB2262745B (en) | Use of steel for cold-rollers | |
| EP0291686A3 (en) | Inhibitors of angiogenin | |
| ZA932553B (en) | New use of B-carbolines | |
| GB2217729B (en) | Obtenation of scualane | |
| EP0411395A3 (en) | Use of ace inhibitors for atherosclerosis-prophylaxis | |
| GB8721800D0 (en) | Measuring proximity of metal object | |
| ZA876806B (en) | Pharmaceutical composition comprising a phosphodiesterase inhibitor and a thromboxane a2 antagonist | |
| GB8800792D0 (en) | Taper rolling of metal | |
| GB2205386B (en) | Cartridging of explosives | |
| IE872432L (en) | Composition of a phosphodiesterase and a thromboxane a2¹antagonist | |
| MW1588A1 (en) | Cartridging of explosives | |
| ZA889365B (en) | Hydrates of andinotropic agent | |
| BG43631A1 (en) | Methodfor corrosion protection of molybdene workpieces | |
| GB8717404D0 (en) | Temporary blocking of bore pipe | |
| IE862859L (en) | INHIBITORS OF DOPAMINE-ß-HYDROXYLASE | |
| GB9303518D0 (en) | Combinations of retroviral inhibitors | |
| IE882928L (en) | Use of thromboxane b2 | |
| BG46662A1 (en) | Inhibitor of urease |